Cidara Thera (CDTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 1,275 | 23,283 | 64,448 | 49,572 | 12,067 |
| Gross Profit | 1,275 | 23,283 | 64,448 | 49,572 | 12,067 |
| Operating Expenses | 177,377 | 50,343 | 97,951 | 91,827 | 83,916 |
| Operating Income | -176,102 | -27,060 | -33,503 | -42,255 | -71,849 |
| Other Income | 5,811 | 1,995 | 191 | -212 | -262 |
| Pre-tax Income | -170,291 | -25,065 | -33,312 | -42,467 | -72,111 |
| Income Tax | 0 | 15 | 272 | N/A | N/A |
| Net Income Continuous | -170,291 | -25,080 | -33,584 | -42,467 | -72,111 |
| Net Income Discontinuous | 464 | 2,149 | N/A | N/A | N/A |
| Net Income | $-169,827 | $-22,931 | $-33,584 | $-42,467 | $-72,111 |
| EPS Basic Total Ops | -26.75 | -5.25 | -9.60 | -16.20 | -36.00 |
| EPS Basic Continuous Ops | -26.82 | -5.74 | -9.62 | -16.19 | -34.70 |
| EPS Basic Discontinuous Ops | 0.07 | 0.49 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -26.75 | -5.25 | -9.60 | -16.20 | -36.00 |
| EPS Diluted Continuous Ops | -26.82 | -5.74 | -9.62 | -16.19 | -34.70 |
| EPS Diluted Discontinuous Ops | 0.07 | 0.49 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -26.82 | -5.20 | -8.60 | -16.20 | -36.00 |
| EBITDA(a) | $-175,685 | $-26,865 | $-33,360 | $-43,482 | $-70,794 |